Skip to main content
. 2022 May 24;12:875188. doi: 10.3389/fonc.2022.875188

Figure 1.

Figure 1

Disrupted pathways in pancreatic cancer: Disruptions in K-Ras, hypoxia, Notch signaling, MAPK, PI3K/Akt and TGF-β signaling pathways lead to EMT and CSCs development, which ultimately expedite metastasis and chemoresistance in pancreatic cancer patients.